CT Vision (International) Holdings announced two equity financing transactions on 27 May 2026 that could inject up to HK$64.80 million in gross proceeds and HK$63.60 million in net proceeds into the group, earmarked primarily for its renewable energy and emerging aerospace businesses.

Issue of 30 Million Subscription Shares • CT Vision has signed a Subscription Agreement with Arta Asset Management to issue 30 million new shares at HK$0.36 each. • The shares equate to 2.70% of existing issued capital and 2.63% post-issue (2.32% after both transactions). • Gross proceeds: HK$10.80 million; net proceeds: approximately HK$10.60 million, implying a net price of HK$0.3534 per share. • All net proceeds are allocated to the development of the group’s renewable energy segment. • Listing approval for the new shares must be obtained from the Hong Kong Stock Exchange by 12 June 2026 for the deal to complete.

Placing of up to 150 Million Shares • Under a best-efforts Placing Agreement with Theia Securities, the company may issue up to 150 million new shares at HK$0.36 each to at least six independent investors. • The placement represents 13.50% of current issued shares, falling to 11.90% of the enlarged base post-placing and 13.94% after both transactions. • Gross proceeds: HK$54.00 million; net proceeds: approximately HK$53.00 million, giving the same net price of HK$0.3534 per share. • Intended use of net proceeds: HK$33.00 million for renewable energy expansion and HK$20.00 million for entry into commercial aerospace activities. • Completion is conditional on Stock Exchange listing approval by 17 June 2026.

Funding Structure and Dilution • Both the Subscription and Placing will be executed under the existing General Mandate, which authorises issuance of up to 185.60 million new shares. • Post-transactions, issued share capital could rise from 1.11 billion to 1.29 billion shares, diluting existing holders by up to 16.2%. • Major shareholders CT Vision Investment, CT Vision Strategic and Golden Orange will see their combined stake fall from 52.44% to 45.13% if both deals close.

Connected-Party Aspect • The Placing Agent, Theia Securities, is an associated company of Executive Director Sun Dexin and Non-Executive Director Dr Ho Chun Kit Gregory. The 1.5% placing commission is classified as a de minimis connected transaction under Listing Rule 14A.76(1).

Strategic Rationale • Management cites accelerated investment needs in China’s renewable energy market, where installed renewable capacity surpassed coal in 2026, and the group’s planned entry into aerospace services, satellite data computing and trading. • Combined net proceeds of approximately HK$63.60 million are intended to strengthen the balance sheet and fund these growth initiatives.

Timeline and Risk Reminder • Subscription completion target: three business days after listing approval and no later than 12 June 2026. • Placing completion target: three business days after listing approval and no later than 17 June 2026. • Both transactions are independent and may not proceed if the respective conditions are unmet; investors are advised to exercise caution when dealing in CT Vision shares.